Topic: Texas Institute for Drug and Diagnostic Development

University of Texas at Austin Researchers Awarded $4.7 Million for Cancer Research

April 7, 2011

Faculty from The University of Texas at Austin have been awarded $4.7 million from the Cancer Prevention Research Institute of Texas (CPRIT) for research to further understand cancer biology and develop new cancer treatments.

Read more

Silicon Valley Entrepreneur and Researcher to Lead Commercialization at The University of Texas at Austin

Sept. 13, 2010

Richard A. Miller, M.D., a veteran biotechnology entrepreneur from Silicon Valley, has been named chief commercialization officer and research professor at The University of Texas at Austin.

Read more

Researchers to Further Cancer Research with $3.3 Million in Grants

July 1, 2010

Researchers at The University of Texas at Austin have received $3.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to train a new generation of cancer researchers and study processes related to cancer cell growth and death.

Read more

Next-Generation Gene Sequencing Technology Enables Advanced Genomic Research

Jan. 29, 2009

A newly installed next-generation genome analysis technology will help scientists at The University of Texas at Austin rapidly catalog large genomes and further push the boundaries of genomic research.

Read more